Skip to main content
Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients

Fig. 5

Serum levels of galectin-9 in RA patients with or without DAS28-ESR clinical remission (CR). We compared serum levels of galectin-9 between RA patients with or without clinical remission (CR). Serum levels of galectin-9 were significantly lower in patients with CR compared to those without CR in RA patients with low titers of ACPA (< 200 U/ml), whereas there was no significant difference in serum levels of galectin-9 between patients with and without CR in RA patients with high titers of ACPA ( 200 U/ml)

Back to article page